Related Experiment Video

Updated: Aug 16, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Hypertension and the cardiometabolic syndrome

Camila Manrique1, Guido Lastra, Adam Whaley-Connell

  • 1Department of Internal Medicine, University of Missouri School of Medicine, Columbia, MO 65212, USA.

Journal of Clinical Hypertension (Greenwich, Conn.)
|August 17, 2005
PubMed

Insights

Hypertension is linked to metabolic issues like insulin resistance and obesity, forming the cardiometabolic syndrome. Targeting these metabolic factors may offer new treatment approaches for hypertension and related cardiovascular diseases.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Syndrome Research
  • Hypertension Studies

Background:

  • Hypertension and cardiovascular disease are major causes of death.
  • Hypertension is increasingly recognized as part of the cardiometabolic syndrome, encompassing insulin resistance, obesity, dyslipidemia, and inflammation.
  • Tissue renin-angiotensin-aldosterone system activation is implicated in endothelial dysfunction and metabolic abnormalities.

Purpose of the Study:

  • To explore the relationship between hypertension and the components of the cardiometabolic syndrome.
  • To highlight the role of the renin-angiotensin-aldosterone system in hypertension-related complications.
  • To propose a new treatment paradigm for hypertension based on its metabolic aspects.

Main Methods:

  • Review of accumulating data and existing evidence.
  • Analysis of the components of cardiometabolic syndrome.
  • Examination of the role of tissue renin-angiotensin-aldosterone system activation.

Main Results:

  • Hypertension shares several vascular and metabolic abnormalities with the cardiometabolic syndrome.
  • Insulin resistance, central obesity, dyslipidemia, inflammation, and oxidative stress are key components.
  • Renin-angiotensin-aldosterone system activation contributes to endothelial dysfunction, microalbuminuria, and insulin resistance.

Conclusions:

  • Hypertension is both a vascular and a metabolic disease.
  • Understanding hypertension as a metabolic disorder opens new therapeutic avenues.
  • Targeting metabolic dysfunction alongside vascular factors may improve outcomes for hypertension and cardiometabolic syndrome.

More Related Videos

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...